SONM DNA X, Inc.
Telephone & Telegraph Apparatus · Nasdaq · SEC CIK 1178697 · Fiscal year ends 12/31
Financial factors as of 2025-09-30 (2025Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.2%
TTM net income YoY-149.4%
TTM EPS YoY-115.8%
Revenue 3-yr CAGR-1.4%
Net income 3-yr CAGR—
Margins
Gross margin18.3%
Operating margin-48.1%
Net margin-56.5%
FCF margin—
EBITDA margin-41.8%
Returns
ROE-455.8%
ROA-74.7%
ROIC (approx.)-527.3%
Asset turnover1.32x
Leverage & solvency
Liabilities / assets101.7%
Debt / equity—
Current ratio0.78x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.78x
Accruals ratio-16.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | $58.30M |
| Cost of revenue | — | $48.38M |
| Gross profit | — | $9.92M |
| R&D expense | — | $14.23M |
| SG&A expense | $5.41M | $3.10M |
| Operating income | -$5.41M | -$3.10M |
| Interest expense | $945,000 | — |
| Pretax income | -$7.96M | -$2.88M |
| Income tax | -$1.15M | $226,000 |
| Net income | -$20.66M | -$33.65M |
| EBITDA | -$1.11M | $457,000 |
| EPS (basic) | -28.58 | -128.37 |
| EPS (diluted) | -28.58 | -128.37 |
| Weighted avg. shares (diluted) | 722,689 | 262,118 |
| Banking | ||
| Provision for credit losses | — | $2.29M |
| Balance sheet | ||
| Cash & equivalents | $1.30M | $5.34M |
| Receivables | — | $4.34M |
| Inventory | — | $10.62M |
| Current assets | $28.91M | $32.16M |
| PP&E, net | — | $227,000 |
| Total assets | $43.90M | $39.74M |
| Current liabilities | $50.62M | $43.74M |
| Short-term debt | $5.07M | — |
| Long-term debt | $5.07M | — |
| Total debt | $10.13M | — |
| Total liabilities | $50.62M | $45.44M |
| Shareholders' equity | -$7.96M | -$5.70M |
| Net debt | $8.83M | — |
| Shares outstanding | 1.27M | 276,881 |
| Cash flow statement | ||
| Operating cash flow | -$23.53M | -$8.49M |
| Capital expenditure | — | $214,000 |
| Free cash flow | — | -$8.70M |
| Investing cash flow | — | -$214,000 |
| Financing cash flow | $19.49M | $4.65M |
| Depreciation & amortization | $4.30M | $3.56M |
| Stock-based compensation | $1.54M | $1.52M |
Free plan shows the latest 2 periods; Pro shows all 8 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.